Prediabetes

Prediabetes Screening and Management

An on-demand article for healthcare professionals seeking to improve health outcomes for patients at risk of developing diabetes.

  • Contact hours: 0.5 (0.05 CEU)
  • Registration is free of charge

Activity Description

Prediabetes is characterized by glucose levels which are elevated, but do not meet criteria for diabetes. Currently, there are 96 million individuals in the United States with prediabetes, which is 1 in 3 adults. Of these individuals, 80% are unaware of their condition. In New York State, it is estimated that over 5 million people have prediabetes, with 1.5 million reported diagnoses. Projections indicate that prediabetes could affect 1 billion people worldwide by 2045. Prediabetes is associated with obesity, dyslipidemia, and hypertension, and indicates an elevated risk of type 2 diabetes, heart disease, and stroke. By spreading awareness and implementing appropriate screening and interventions, disease progression may be prevented to improve overall health outcomes.

Learning Objectives
 
  1. Define the diagnostic criteria for prediabetes.
  2. Identify patient risk factors and indications for prediabetes screening.
  3. Discuss management strategies that incorporate recommended lifestyle modifications, pharmacotherapy, and/or surgical intervention. 
Activity Contributors
Edward M Bednarczyk, PharmD, FACCP, FAPhA
Director, cHOPE
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Mia Bersani
PharmD Candidate 2024
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Marsha Nelson
Associate Director, Office of Continuing Pharmacy Education
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Barbara Rogler, PharmD, MS
Clinical Assistant Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Alexia Sroka, PharmD, BCPS
Coordinator, MPEP
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Deborah Targoff, PharmD
Senior Research Scientist
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
 
Intended Audience

Physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare providers.

Cost and Registration

There is no fee for this activity. The program is supported by the New York State Department of Health Medicaid Prescriber Education Program (MPEP).

Accreditation and Certification Information

For physicians/providers:

Accreditation: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by ACCME to provide continuing medical education for physicians.

Certification: The University at Buffalo Jacobs School of Medicine and Biomedical Sciences designates this internet enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit (TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For pharmacists: 

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity has been assigned ACPE # 0044-0000-23-045-H01-P and will award 0.5 contact hours (0.05 CEU) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor for those who complete all components of this activity.

Activity Components for Continuing Education Credit
To obtain continuing education credit, register and complete the required materials. This continuing education activity contains a pre-test, written article, post-test, and program evaluation. Credit will be awarded upon successful completion of the post-test activity, with a score of 70% or better.
 
Initial release date: 10/20/2023
Expiration date: 10/20/2026
Educational Content